# EXACOS EG Population

> **NCT06983340** · — · WITHDRAWN · sponsor: **AstraZeneca**

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06983340
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-08-30
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study withdrawn since it was rejected by local regulatory authority.
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06983340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06983340, "EXACOS EG Population". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06983340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*